MicroRNA expression profiles of whole blood in lung adenocarcinoma
about
Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current LiteratureCirculating microRNAs: potential biomarkers for common malignanciesmiR-190b is markedly upregulated in the intestine in response to simian immunodeficiency virus replication and partly regulates myotubularin-related protein-6 expressionMicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression.miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan.MicroRNAs as lung cancer biomarkersCirculating miRNAs as new blood-based biomarkers for solid cancers.Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial eraRoles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer.Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?Expression of MALAT1 in the peripheral whole blood of patients with lung cancer.Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease.Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinomaIntegrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology.Muscle-Enriched MicroRNAs Isolated from Whole Blood Are Regulated by Exercise and Are Potential Biomarkers of Cardiorespiratory Fitness.Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter studymiRNAs as non-invasive biomarkers for lung cancer diagnosis.Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.miRNA detection methods and clinical implications in lung cancer.MiR-942 decreased before 20 weeks gestation in women with preeclampsia and was associated with the pathophysiology of preeclampsia in vitro.MicroRNA-190b confers radio-sensitivity through negative regulation of Bcl-2 in gastric cancer cells.MiR-630 inhibits invasion and metastasis in esophageal squamous cell carcinoma.microRNAs Expression as Novel Genetic Biomarker for Early Prediction and Continuous Monitoring in Pulmonary Cancer.Whole blood microRNA markers are associated with acute respiratory distress syndrome.Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes.MicroRNA levels quantified in whole blood varies from PBMCs.HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB SignalingIdentification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases.Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.miRNA‑1284 inhibits cell growth and induces apoptosis of lung cancer cells.The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.Unique circulating microRNAs in relation to EGFR mutation status in Japanese smoker male with lung adenocarcinoma.Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.
P2860
Q24289207-64E3B932-9D2F-48EE-97FE-A2746B03CE85Q26752611-926B7F40-0FDF-41BF-8BD5-889C874018C2Q28081347-DD48D45E-370D-4BF3-90DB-EC64BFE104CCQ28390816-E84A4398-3AE2-4EDA-98F9-74CA65262F2BQ31133114-89DA4F0A-9B4B-4913-978E-A11F37134D75Q33773806-93B69C1E-7316-48FB-9A5F-7CE7BD517B4BQ34031213-3898C244-C070-4B88-B004-71E77A026B21Q34331651-AB643DFB-A56A-49E2-BAAC-D435E54CE002Q34840130-632BE0D1-E43B-426F-A397-3B7322B6DDCEQ34997260-28D18CBA-B2F3-4982-BA08-241EEF4314C2Q35082591-ACE2C01E-7903-46A7-83EA-6825B0AC09C7Q35107341-B12EE339-7368-40BF-950B-1FD5CC14A208Q35682549-8038EFAB-34DF-4E8C-B98F-8977900152E2Q35742035-67E081A4-0CE4-45F5-900A-6B18A73D7B82Q35768989-28BB7B3D-C534-479D-9A1E-800852A080DCQ35806902-FB7982A9-BFB1-410C-BE75-A168CB40A126Q36840404-47A35270-A846-4BFD-A680-D29FA14F7A89Q36913743-62DB4F8E-15E4-4352-AA98-7C89B58363A5Q37295585-2F688710-9437-46A5-A008-091B336F775FQ37404575-29CAC56C-9F33-4A14-90F3-B0F64842C470Q37413435-D04117DD-AB2B-4C52-8A95-8A8E1B3CC6F8Q37520294-0C704367-C623-40F4-AF5B-CD767FA63C10Q38221221-170F67E2-10BB-4335-8EF6-606DD58C218DQ38273758-08FC0CEF-5229-4050-87B4-107A63B6EDAEQ38282466-5D6B4BDA-C8B7-41A2-A0A9-8DDD7C1FF68BQ38712440-D5D39D38-403C-449C-B17D-7F32D947EE05Q38723197-02AC63F8-4EB5-4F39-813B-CB97AE9DC09DQ38749995-6D819935-6161-4685-9C76-8E672CF78141Q39077744-9C02287E-7CB8-4D29-A6B9-ACB9D1A15524Q40063802-6750189A-381F-4C4B-AB5F-A5E393DDE97EQ40221884-A3C2D99C-CEAA-47A4-AA1B-E6A6D5B733E9Q40393662-A24195BB-2F41-474A-9193-C8FC9AC4B584Q40605490-415DFBB0-05BF-4B35-BB01-DC1D39571F15Q41008487-369D819A-25C1-4658-BBF9-1AF442592960Q41118667-5DC36EE3-2F91-4593-93F7-1602B8A2F965Q42546858-B96A21D1-0E49-46A3-95A2-74040AA132F8Q45937007-C195D6C2-C7E5-4C18-9507-F67A980F0C40Q48518834-E2774502-AA89-4D92-A9FC-0D589A63763FQ54089180-02380ED0-BE27-4853-A828-ACCBC989E1E7
P2860
MicroRNA expression profiles of whole blood in lung adenocarcinoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@ast
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@en
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@nl
type
label
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@ast
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@en
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@nl
prefLabel
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@ast
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@en
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@nl
P2093
P2860
P1433
P1476
MicroRNA expression profiles of whole blood in lung adenocarcinoma
@en
P2093
Anil Vachani
Eric Kannisto
John C Kucharczuk
Santosh K Patnaik
Sunil Singhal
P2860
P304
P356
10.1371/JOURNAL.PONE.0046045
P407
P577
2012-09-28T00:00:00Z